Health1 month ago
uniQure Faces Setback as FDA Questions AMT-130’s Efficacy
uniQure has encountered a significant setback as the Food and Drug Administration (FDA) expressed doubts regarding the efficacy of its experimental treatment, AMT-130, for Huntington’s disease....
